B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 700 KRW 1.99% Market Closed
Market Cap: 433.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioPlus Co Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Free Cash Flow
-â‚©5.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Free Cash Flow
-â‚©387B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Free Cash Flow
-â‚©137.3B
CAGR 3-Years
-6%
CAGR 5-Years
-29%
CAGR 10-Years
-42%
T
T&L Co Ltd
KOSDAQ:340570
Free Cash Flow
â‚©17.7B
CAGR 3-Years
44%
CAGR 5-Years
38%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Free Cash Flow
â‚©25.7B
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Free Cash Flow
â‚©8.8B
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
15%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

What is BioPlus Co Ltd's Free Cash Flow?
Free Cash Flow
-5.5B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Free Cash Flow amounts to -5.5B KRW.

Back to Top